GGrantIndex
Sort

64,565 grants matching drug discovery

Kinetic Biomarker for CLL Prognosis

$679,502
Scott M Turner · Kinemed, Inc. · R44 · FY2007 · CA

Kv7.2/7.3 Activators for the Treatment of Epilepsy Disorders

$679,492
Michael Bozik · Knopp Biosciences, Llc · U44 · FY2019 · NS

Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits

$679,487
Thota Ganesh · Emory University · UH3 · FY2023 · NS

Unusual Pharmacophores and New Tools for Cross-Coupling

$679,470
Ryan Ashok Shenvi · Scripps Research Institute, The · R35 · FY2022 · GM

Clinical Trials of Flavopiridol with Chemotherapy

$679,347
Gary K Schwartz · Sloan-Kettering Inst Can Research · R01 · FY2008 · CA

Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology

$679,275
Laura M Bohn · Scripps Florida · R01 · FY2013 · DA

A network approach to interrogate cellular plasticity and drug resistance in cancer

$679,232
Rosemary J Akhurst · University Of California, San Francisco · R01 · FY2025 · CA

Developing liquid biopsy tests for malignant effusions using artificial intelligence-assisted, morphology-based isolation of tumor cells

$679,188
Mark Jesus Magbanua · University Of California, San Francisco · R01 · FY2024 · CA

Pharmacological Validation of Vascular KATP Channels for Modulating Ductus Arteriosus Tone

$679,091
Jerod S Denton · Vanderbilt University Medical Center · R01 · FY2020 · HD

Early-Stage Preclinical Validation of Carbon Monoxide Prodrugs for Acute Kidney Injury

$678,976
Binghe Wang · Georgia State University · R01 · FY2024 · DK

NK Cell Activation and Function in HIV-1 Exposed Uninfected IV Drug Users

$678,940
Luis J. Montaner · Wistar Institute · R01 · FY2012 · DA

Targeting RIPK3 in Flu-Associated Lung Injury

$678,878
Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2020 · AI

Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children

$678,833
Paul W. Burridge · Northwestern University At Chicago · R01 · FY2025 · CA

Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children

$678,833
Paul W. Burridge · Northwestern University At Chicago · R01 · FY2023 · CA

Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children

$678,833
Paul W. Burridge · Northwestern University At Chicago · R01 · FY2024 · CA

Project 1: Systematic discovery of cell-intrinsic mechanisms of cancer drug resistance

$678,713
Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2018 · CA

Discovery of SARS-CoV-2 antivirals using a replicon assay

$678,703
Stefan G Sarafianos · Emory University · R01 · FY2024 · AI

Regulating dopamine transport through allosteric modulation - Functional and Behavioral Studies

$678,663
Ole Valente Mortensen · Drexel University · R01 · FY2024 · DA

Administration and Mgmt (California)

$678,662
Hugh Rosen · Scripps Research Institute, The · U54 · FY2012 · MH

Chemogenomic Profiling of Plasmodium Falciparum Responses and Resistance

$678,606
John Adams · University Of South Florida · R01 · FY2023 · AI

Synthetic hydrogels for biomanufacturing of iPSC-derived neural cells for precision medicine

$678,585
Connie S Lebakken · Stem Pharm, Inc. · R44 · FY2021 · NS

Significance of Epac signaling in renal Na+handling and hypertension

$678,566
Oleh Pochynyuk · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · DK

Significance of Epac signaling in renal Na+handling and hypertension

$678,566
Oleh Pochynyuk · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · DK

DEFINING RAPTOR-MEDIATED MECHANISMS OF HYPOXIC INJURY

$678,547
C. Michael Crowder · University Of Washington · R01 · FY2023 · NS

Mechanistic and Translational Determination of PERK-targeting Strategies for Non-surgical Management of Abdominal Aortic Aneurysm

$678,529
K Craig Kent · University Of Virginia · R01 · FY2024 · HL